OrderlyMeds is one of the price leaders in compounded GLP-1 telehealth — its starter pricing is among the most aggressive anywhere, and like Pallas it has stayed in compounded medicine while most large platforms went branded-only. The two share a lot structurally: no membership fee, flat pricing at every dose, free shipping, all 50 states. So this comparison comes down to the numbers themselves, the brand-name tier, and one unusual cancellation clause worth understanding before you enroll anywhere.
Pricing on both sides changes often; figures reflect each platform's published pricing as of August 2026 — confirm current numbers on both sites before signing up.
The three differences that matter most
- The semaglutide number — OrderlyMeds is lower, and we'll say so. OrderlyMeds prices compounded semaglutide at $74/month for the first two months (billed $149 up front for new GLP-1 patients), then $149/month ongoing, flat at every dose. Pallas's compounded semaglutide injection is $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. On the semaglutide line item alone, OrderlyMeds costs less. Tirzepatide is closer to a wash: OrderlyMeds runs $149/month to start, then $299/month — and Pallas's tirzepatide injection is $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime.
- The cancellation clause. Per OrderlyMeds' own FAQ, you can cancel anytime before the doctor finalizes your prescription (with a full refund if you're denied) — but "once your prescription is written after your medical consultation, cancellation is no longer possible" for that order. Pallas's terms run the other way: nothing is charged until a clinician prescribes, and you can cancel your plan anytime, self-serve, in the portal.
- Brand-name pricing. Both platforms list FDA-approved brands. As of August 2026, OrderlyMeds lists Wegovy® at $1,839/month and Zepbound® at $1,498/month; Pallas's brand-name pens are $499 for the first month, then from $599/month. If the brand tier is where you might land, Pallas is the cheaper path of the two.
About compounded medications
Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. A licensed clinician decides whether a compounded preparation — for example, a dose level or a formulation a brand-name product doesn't offer — is appropriate for you.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Quick comparison
| Pallas Health | OrderlyMeds | |
|---|---|---|
| Compounded semaglutide injection | Yes — one all-in plan price | Yes — $74/mo first 2 months (new patients), then $149/mo |
| Compounded tirzepatide injection | Yes — one all-in plan price | Yes — $149/mo first 2 months, then $299/mo |
| FDA-approved brand (Wegovy®, Zepbound®) | Yes — $499 first month, then from $599/mo, cash-pay | Yes — Wegovy® $1,839/mo, Zepbound® $1,498/mo |
| Membership fee | None | None |
| Price changes as your dose increases | No — flat at every dose | No — flat at every dose |
| If a clinician doesn't prescribe | Nothing charged | Full refund if denied |
| Cancellation after a prescription is written | Cancel your plan anytime, self-serve | "No longer possible" for that order, per their FAQ |
| States served | All 50 + DC | All 50 |
| Care delivery | 100% online, async in most states | Async-first; video where their FAQ says state law requires |
| Companion app | Free on iOS and Android, no subscription | Not offered |
| Year founded | 2026 | 2024 |
What OrderlyMeds does well
Price leadership on compounded semaglutide. A $74/month starter rate and a $149/month renewal — flat at every dose, with no membership and cold-chain shipping included — is genuinely among the lowest published in the category. They also run discounted transfer pricing for patients already on a GLP-1.
Simple structure. Like Pallas, OrderlyMeds avoids the membership-plus-medication model: one number covers the provider consult, the medication, and shipping. Approval decisions typically come within 24–48 hours, and the platform bundles extras like nutrition content and therapy-service access.
It stayed in compounding. Alongside Pallas, Mochi, and a handful of others, OrderlyMeds continues to offer compounded semaglutide and tirzepatide after most large platforms went branded-only in 2026.
What Pallas does differently
Terms you can leave. The structural difference that matters most: Pallas plans can be canceled anytime — before or after a prescription exists — with nothing charged until a clinician prescribes, and no order that locks. Those plans are compounded semaglutide and compounded tirzepatide injections, one price with clinician care included. OrderlyMeds refunds fully if you're denied, but by its own FAQ, cancellation is no longer possible once your prescription is written. Read both policies; they lead to different places if your plans change mid-cycle.
The cheaper brand tier, dispensed in one place. Pallas dispenses FDA-approved Wegovy®, Ozempic®, Zepbound®, and Mounjaro® cash-pay at $499 for the first month and then from $599/month — roughly $900–1,200/month below OrderlyMeds' listed brand prices as of August 2026. If your clinician moves you between compounded and brand over time, that tier pricing compounds quickly.
What to verify. Whatever platform you consider, check its status in LegitScript's public database, state clinician licensure, and US-licensed pharmacy sourcing.
A free companion app and a self-serve portal. The Pallas companion app (iOS and Android) tracks protein, steps, weight trend, and dose reminders; the portal handles orders, refills, plan switches, billing, and anytime provider messaging — no phone queue.
The pricing math
For compounded semaglutide, OrderlyMeds' ongoing rate is meaningfully below Pallas's per-month average — if the monthly number is your deciding factor and the terms suit you, they price it sharply and we won't pretend otherwise. For compounded tirzepatide, the ongoing rates land within a dollar of each other, and Pallas charges nothing until a clinician prescribes. For brand-name medication, Pallas is the cheaper platform of the two by a wide margin. Across all three: compare the cancellation and refund terms with the same care you give the price — that's where these two structures genuinely differ.
Who should pick which
OrderlyMeds is probably the better fit if:
- The lowest ongoing compounded-semaglutide price is your deciding factor
- You're transferring from another GLP-1 platform and want discounted transfer pricing
- You're comfortable with orders being final once a prescription is written
Pallas is probably the better fit if:
- You want cancel-anytime terms with no order lock, and nothing charged unless a clinician prescribes
- You may want brand-name medication now or later — Pallas's brand tier is substantially cheaper
- You want a self-serve portal and anytime provider messaging
- You'd use a free companion app (iOS and Android) for protein, steps, and dose tracking
Switching between them
Bring your medication name, current dose, and titration history (OrderlyMeds' transfer tier expects them anyway; Pallas's intake asks the same). A new clinician picks up from your current dose — no restart of titration unless you've been off medication for more than four weeks. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.
Bottom line: OrderlyMeds prices compounded semaglutide lower than almost anyone — including Pallas — with the same no-membership, flat-at-every-dose structure. Pallas answers with terms: cancel anytime with no order lock, nothing charged until a clinician prescribes, brand-name medications dispensed at $400–800/month less, and a self-serve portal with a free companion app. If the monthly semaglutide number decides it, price OrderlyMeds against ours; if the exit terms or brand tier decide it, that's the Pallas side of the ledger.
